Results of the phase 2 54767414MMY2002 (Sirius) trial of daratumumab for multiple myeloma | Dr Joseph Mikhael at Annual Meeting 2015 - 101271

Spotlight
Video

Results of the phase 2 54767414MMY2002 (Sirius) trial of daratumumab for multiple myeloma | Dr Joseph Mikhael at Annual Meeting 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph R. Mikhael, MD, of Mayo Clinic, Scottsdale, AZ, discusses the results of the phase 2 54767414MMY2002 (Sirius) trial of daratumumab monotherapy in patients with at least 3 lines of prior therapy or double refractory multiple myeloma. Daratumumab is a novel therapeutic human CD38 monoclonal antibody.

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 06/19/15
Added : 3 years ago
Category : Multiple Myeloma